Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Isolation of Candida auris from cystic fibrosis patient, Greece, April 2019.

Stathi A, Loukou I, Kirikou H, Petrocheilou A, Moustaki M, Velegraki A, Zachariadou L.

Euro Surveill. 2019 Jul;24(29). doi: 10.2807/1560-7917.ES.2019.24.29.1900400.

2.

The lipid profile of three Malassezia species assessed by Raman spectroscopy and discriminant analysis.

Petrokilidou C, Pavlou E, Gaitanis G, Bassukas ID, Saridomichelakis MN, Velegraki A, Kourkoumelis N.

Mol Cell Probes. 2019 Aug;46:101416. doi: 10.1016/j.mcp.2019.06.006. Epub 2019 Jun 25.

PMID:
31247316
3.

Variation of cultured skin microbiota in mothers and their infants during the first year postpartum.

Gaitanis G, Tsiouri G, Spyridonos P, Stefos Τ, Stamatas GN, Velegraki A, Bassukas ID.

Pediatr Dermatol. 2019 Jul;36(4):460-465. doi: 10.1111/pde.13829. Epub 2019 Apr 25.

PMID:
31025407
4.

Genotypes and population genetics of cryptococcus neoformans and cryptococcus gattii species complexes in Europe and the mediterranean area.

Cogliati M, Desnos-Ollivier M, McCormick-Smith I, Rickerts V, Ferreira-Paim K, Meyer W, Boekhout T, Hagen F, Theelen B, Inácio J, Alonso B, Colom MF, Trilles L, Montagna MT, De Donno A, Susever S, Ergin C, Velegraki A, Ellabib MS, Nardoni S, Macci C, Trovato L, Dipineto L, Akcaglar S, Mlinaric-Missoni E, Bertout S, Vencá ACF, Sampaio AC, Criseo G, Ranque S, Çerikçioğlu N, Marchese A, Vezzulli L, Ilkit M, Pasquale V, Polacheck I, Lockhart SR.

Fungal Genet Biol. 2019 Aug;129:16-29. doi: 10.1016/j.fgb.2019.04.001. Epub 2019 Apr 3.

PMID:
30953839
5.

Changing Epidemiology of Invasive Candidiasis in Children during a 10-Year Period.

Noni M, Stathi A, Vaki I, Velegraki A, Zachariadou L, Michos A.

J Fungi (Basel). 2019 Feb 22;5(1). pii: E19. doi: 10.3390/jof5010019.

6.

Antifungal activity of selected Malassezia indolic compounds detected in culture.

Gaitanis G, Magiatis P, Mexia N, Melliou E, Efstratiou MA, Bassukas ID, Velegraki A.

Mycoses. 2019 Jul;62(7):597-603. doi: 10.1111/myc.12893. Epub 2019 May 8.

PMID:
30636018
7.

Septic shock due to Candida famata (Debaryomyces hansenii) candidemia in an ICU immunocompetent trauma-patient.

Karapetsa M, Tsolaki V, Arabatzis M, Petinaki E, Velegraki A, Zakynthinos E.

J Infect Public Health. 2019 Jul - Aug;12(4):594-597. doi: 10.1016/j.jiph.2018.12.015. Epub 2019 Jan 8.

8.

Humanome Versus Microbiome: Games of Dominance and Pan-Biosurveillance in the Omics Universe.

Kambouris ME, Gaitanis G, Manoussopoulos Y, Arabatzis M, Kantzanou M, Kostis GD, Velegraki A, Patrinos GP.

OMICS. 2018 Aug;22(8):528-538. doi: 10.1089/omi.2018.0096. Epub 2018 Jul 23.

PMID:
30036141
9.

Genetic Factors and Genotype-Environment Interactions Contribute to Variation in Melanin Production in the Fungal Pathogen Cryptococcus neoformans.

Samarasinghe H, Aceituno-Caicedo D, Cogliati M, Kwon-Chung KJ, Rickerts V, Velegraki A, Ackaglar S, Xu J.

Sci Rep. 2018 Jun 29;8(1):9824. doi: 10.1038/s41598-018-27813-3.

10.

A traditional Chinese remedy points to a natural skin habitat: indirubin (indigo naturalis) for psoriasis and the Malassezia metabolome.

Gaitanis G, Magiatis P, Velegraki A, Bassukas ID.

Br J Dermatol. 2018 Sep;179(3):800. doi: 10.1111/bjd.16807. Epub 2018 Jul 4. No abstract available.

PMID:
29791716
11.

Toward Decentralized Agrigenomic Surveillance? A Polymerase Chain Reaction-Restriction Fragment Length Polymorphism Approach for Adaptable and Rapid Detection of User-Defined Fungal Pathogens in Potato Crops.

Kambouris ME, Manoussopoulos Y, Kritikou S, Milioni A, Mantzoukas S, Velegraki A.

OMICS. 2018 Apr;22(4):264-273. doi: 10.1089/omi.2018.0012. Epub 2018 Mar 27.

PMID:
29584542
12.

High variability within Candida albicans transcription factor RLM1: Isolates from vulvovaginal infections show a clear bias toward high molecular weight alleles.

Carvalho-Pereira J, Oliveira MME, Costa-Barbosa A, Vaz C, Velegraki A, Zancopé-Oliveira RM, Pais C, Sampaio P.

Med Mycol. 2018 Jul 1;56(5):649-651. doi: 10.1093/mmy/myx079.

PMID:
29420774
13.

Nail Raman spectroscopy: A promising method for the diagnosis of onychomycosis. An ex vivo pilot study.

Kourkoumelis N, Gaitanis G, Velegraki A, Bassukas ID.

Med Mycol. 2018 Jul 1;56(5):551-558. doi: 10.1093/mmy/myx078.

PMID:
29420760
14.

Rebooting Bioresilience: A Multi-OMICS Approach to Tackle Global Catastrophic Biological Risks and Next-Generation Biothreats.

Kambouris ME, Manoussopoulos Y, Kantzanou M, Velegraki A, Gaitanis G, Arabatzis M, Patrinos GP.

OMICS. 2018 Jan;22(1):35-51. doi: 10.1089/omi.2017.0185. Review.

PMID:
29356627
15.

Fundamental niche prediction of the pathogenic yeasts Cryptococcus neoformans and Cryptococcus gattii in Europe.

Cogliati M, Puccianti E, Montagna MT, De Donno A, Susever S, Ergin C, Velegraki A, Ellabib MS, Nardoni S, Macci C, Trovato L, Dipineto L, Rickerts V, Akcaglar S, Mlinaric-Missoni E, Bertout S, Vencà ACF, Sampaio AC, Criseo G, Ranque S, Çerikçioğlu N, Marchese A, Vezzulli L, Ilkit M, Desnos-Ollivier M, Pasquale V, Polacheck I, Scopa A, Meyer W, Ferreira-Paim K, Hagen F, Boekhout T, Dromer F, Varma A, Kwon-Chung KJ, Inácio J, Colom MF.

Environ Microbiol. 2017 Oct;19(10):4318-4325. doi: 10.1111/1462-2920.13915. Epub 2017 Sep 15.

PMID:
28892309
16.

Culturomics: A New Kid on the Block of OMICS to Enable Personalized Medicine.

Kambouris ME, Pavlidis C, Skoufas E, Arabatzis M, Kantzanou M, Velegraki A, Patrinos GP.

OMICS. 2018 Feb;22(2):108-118. doi: 10.1089/omi.2017.0017. Epub 2017 Apr 12. Review.

PMID:
28402209
17.

Wireless electrostimulation: a new approach in combating infection?

Kambouris ME, Markogiannakis A, Arabatzis M, Manoussopoulos Y, Kantzanou M, Velegraki A.

Future Microbiol. 2017 Mar;12:255-265. doi: 10.2217/fmb-2017-0157. Epub 2017 Feb 20.

PMID:
28262048
18.

First report of canine systemic cryptococcosis owing to Cryptococcus gattii in Europe.

Gerontiti S, Oikonomidis IL, Kalogianni L, Soubasis N, Kritsepi-Konstantinou M, Velegraki A, Komnenou A, Triantafyllou E.

J Small Anim Pract. 2017 Jan;58(1):58-59. doi: 10.1111/jsap.12594. Epub 2016 Nov 21. No abstract available.

PMID:
27868198
19.

Environmental distribution of Cryptococcus neoformans and C. gattii around the Mediterranean basin.

Cogliati M, D'Amicis R, Zani A, Montagna MT, Caggiano G, De Giglio O, Balbino S, De Donno A, Serio F, Susever S, Ergin C, Velegraki A, Ellabib MS, Nardoni S, Macci C, Oliveri S, Trovato L, Dipineto L, Rickerts V, McCormick-Smith I, Akcaglar S, Tore O, Mlinaric-Missoni E, Bertout S, Mallié M, Martins MD, Vencà AC, Vieira ML, Sampaio AC, Pereira C, Criseo G, Romeo O, Ranque S, Al-Yasiri MH, Kaya M, Cerikcioglu N, Marchese A, Vezzulli L, Ilkit M, Desnos-Ollivier M, Pasquale V, Korem M, Polacheck I, Scopa A, Meyer W, Ferreira-Paim K, Hagen F, Theelen B, Boekhout T, Lockhart SR, Tintelnot K, Tortorano AM, Dromer F, Varma A, Kwon-Chung KJ, Inácio J, Alonso B, Colom MF.

FEMS Yeast Res. 2016 Nov;16(7). pii: fow086. No abstract available.

20.

Identification and Characterization of VNI/VNII and Novel VNII/VNIV Hybrids and Impact of Hybridization on Virulence and Antifungal Susceptibility Within the C. neoformans/C. gattii Species Complex.

Aminnejad M, Cogliati M, Duan S, Arabatzis M, Tintelnot K, Castañeda E, Lazéra M, Velegraki A, Ellis D, Sorrell TC, Meyer W.

PLoS One. 2016 Oct 20;11(10):e0163955. doi: 10.1371/journal.pone.0163955. eCollection 2016.

21.

Cornus mas L. (cornelian cherry), an important European and Asian traditional food and medicine: Ethnomedicine, phytochemistry and pharmacology for its commercial utilization in drug industry.

Dinda B, Kyriakopoulos AM, Dinda S, Zoumpourlis V, Thomaidis NS, Velegraki A, Markopoulos C, Dinda M.

J Ethnopharmacol. 2016 Dec 4;193:670-690. doi: 10.1016/j.jep.2016.09.042. Epub 2016 Oct 2. Review.

PMID:
27705748
22.

Effects of Yeast and Bacterial Commensals and Pathogens of the Female Genital Tract on the Transepithelial Electrical Resistance of HeLa Cells.

Tsata V, Velegraki A, Ioannidis A, Poulopoulou C, Bagos P, Magana M, Chatzipanagiotou S.

Open Microbiol J. 2016 Apr 30;10:90-6. doi: 10.2174/1874285801610010090. eCollection 2016.

23.

Epizootic and epidemic dermatophytose outbreaks caused by Trichophyton mentagrophytes from rabbits in Portugal, 2015.

Mesquita JR, Vasconcelos-Nóbrega C, Oliveira J, Coelho C, Vala H, Fratti M, Arabatzis M, Velegraki A, Michel M.

Mycoses. 2016 Oct;59(10):668-73. doi: 10.1111/myc.12513. Epub 2016 Jun 13.

PMID:
27292309
24.

T2Candida Provides Rapid and Accurate Species Identification in Pediatric Cases of Candidemia.

Hamula CL, Hughes K, Fisher BT, Zaoutis TE, Singh IR, Velegraki A.

Am J Clin Pathol. 2016 Jun;145(6):858-61. doi: 10.1093/ajcp/aqw063. Epub 2016 May 31.

PMID:
27247378
25.

Environmental distribution of Cryptococcus neoformans and C. gattii around the Mediterranean basin.

Cogliati M, D'Amicis R, Zani A, Montagna MT, Caggiano G, De Giglio O, Balbino S, De Donno A, Serio F, Susever S, Ergin C, Velegraki A, Ellabib MS, Nardoni S, Macci C, Oliveri S, Trovato L, Dipineto L, Rickerts V, McCormick-Smith I, Akcaglar S, Tore O, Mlinaric-Missoni E, Bertout S, Mallié M, Martins Mda L, Vencà AC, Vieira ML, Sampaio AC, Pereira C, Criseo G, Romeo O, Ranque S, Al-Yasiri MH, Kaya M, Cerikcioglu N, Marchese A, Vezzulli L, Ilkit M, Desnos-Ollivier M, Pasquale V, Korem M, Polacheck I, Scopa A, Meyer W, Ferreira-Paim K, Hagen F, Theelen B, Boekhout T, Lockhart SR, Tintelnot K, Tortorano AM, Dromer F, Varma A, Kwon-Chung KJ, Inácio J, Alonso B, Colom MF.

FEMS Yeast Res. 2016 Jun;16(4). pii: fow045. doi: 10.1093/femsyr/fow045. Epub 2016 May 5. Erratum in: FEMS Yeast Res. 2016 Nov;16(7):. Griseo, Giuseppe [corrected to Criseo, Giuseppe].

26.

Multilocus sequence typing analysis reveals that Cryptococcus neoformans var. neoformans is a recombinant population.

Cogliati M, Zani A, Rickerts V, McCormick I, Desnos-Ollivier M, Velegraki A, Escandon P, Ichikawa T, Ikeda R, Bienvenu AL, Tintelnot K, Tore O, Akcaglar S, Lockhart S, Tortorano AM, Varma A.

Fungal Genet Biol. 2016 Feb;87:22-9. doi: 10.1016/j.fgb.2016.01.003. Epub 2016 Jan 6.

27.

A Prospective, International Cohort Study of Invasive Mold Infections in Children.

Wattier RL, Dvorak CC, Hoffman JA, Brozovich AA, Bin-Hussain I, Groll AH, Castagnola E, Knapp KM, Zaoutis TE, Gustafsson B, Sung L, Berman D, Halasa NB, Abzug MJ, Velegraki A, Sharma TS, Fisher BT, Steinbach WJ.

J Pediatric Infect Dis Soc. 2015 Dec;4(4):313-22. doi: 10.1093/jpids/piu074. Epub 2014 Jul 16.

28.

Performance of three small-scale wastewater treatment plants. A challenge for possible re use.

Kokkinos P, Mandilara G, Nikolaidou A, Velegraki A, Theodoratos P, Kampa D, Blougoura A, Christopoulou A, Smeti E, Kamizoulis G, Vantarakis A, Mavridou A.

Environ Sci Pollut Res Int. 2015 Nov;22(22):17744-52. doi: 10.1007/s11356-015-4988-3. Epub 2015 Jul 9.

PMID:
26154042
29.

International Society of Human and Animal Mycology (ISHAM)-ITS reference DNA barcoding database--the quality controlled standard tool for routine identification of human and animal pathogenic fungi.

Irinyi L, Serena C, Garcia-Hermoso D, Arabatzis M, Desnos-Ollivier M, Vu D, Cardinali G, Arthur I, Normand AC, Giraldo A, da Cunha KC, Sandoval-Denis M, Hendrickx M, Nishikaku AS, de Azevedo Melo AS, Merseguel KB, Khan A, Parente Rocha JA, Sampaio P, da Silva Briones MR, e Ferreira RC, de Medeiros Muniz M, Castañón-Olivares LR, Estrada-Barcenas D, Cassagne C, Mary C, Duan SY, Kong F, Sun AY, Zeng X, Zhao Z, Gantois N, Botterel F, Robbertse B, Schoch C, Gams W, Ellis D, Halliday C, Chen S, Sorrell TC, Piarroux R, Colombo AL, Pais C, de Hoog S, Zancopé-Oliveira RM, Taylor ML, Toriello C, de Almeida Soares CM, Delhaes L, Stubbe D, Dromer F, Ranque S, Guarro J, Cano-Lira JF, Robert V, Velegraki A, Meyer W.

Med Mycol. 2015 May;53(4):313-37. doi: 10.1093/mmy/myv008. Epub 2015 Mar 22.

PMID:
25802363
30.

Pityriazepin and other potent AhR ligands isolated from Malassezia furfur yeast.

Mexia N, Gaitanis G, Velegraki A, Soshilov A, Denison MS, Magiatis P.

Arch Biochem Biophys. 2015 Apr 1;571:16-20. doi: 10.1016/j.abb.2015.02.023. Epub 2015 Feb 24.

31.

Invasive Candida infections in surgical patients in intensive care units: a prospective, multicentre survey initiated by the European Confederation of Medical Mycology (ECMM) (2006-2008).

Klingspor L, Tortorano AM, Peman J, Willinger B, Hamal P, Sendid B, Velegraki A, Kibbler C, Meis JF, Sabino R, Ruhnke M, Arikan-Akdagli S, Salonen J, Dóczi I.

Clin Microbiol Infect. 2015 Jan;21(1):87.e1-87.e10. doi: 10.1016/j.cmi.2014.08.011. Epub 2014 Oct 12.

32.

Malassezia infections in humans and animals: pathophysiology, detection, and treatment.

Velegraki A, Cafarchia C, Gaitanis G, Iatta R, Boekhout T.

PLoS Pathog. 2015 Jan 8;11(1):e1004523. doi: 10.1371/journal.ppat.1004523. eCollection 2015 Jan. Review. No abstract available.

33.

Soluble urokinase plasminogen activator receptor level is an independent predictor of the presence and severity of coronary artery disease and of future adverse events.

Eapen DJ, Manocha P, Ghasemzadeh N, Patel RS, Al Kassem H, Hammadah M, Veledar E, Le NA, Pielak T, Thorball CW, Velegraki A, Kremastinos DT, Lerakis S, Sperling L, Quyyumi AA.

J Am Heart Assoc. 2014 Oct 23;3(5):e001118. doi: 10.1161/JAHA.114.001118. Erratum in: J Am Heart Assoc. 2015 Jan;4(1):e000563. Ghasemzedah, Nima [Corrected to Ghasemzadeh, Nima]. Erratum in: J Am Heart Assoc. 2015 Jan 5;4(1):e000563.

34.

Yeast central nervous system infection in a critically ill patient: a case report.

Frantzeskaki F, Diakaki C, Rizos M, Theodorakopoulou M, Papadopoulos P, Antonopoulou A, Nikitas N, Lignos M, Brountzos E, Velegraki A, Paramythiotou E, Panagyotides J, Armaganidis A, Dimopoulos G.

J Med Case Rep. 2014 Jul 15;8:253. doi: 10.1186/1752-1947-8-253.

35.

Caspofungin at catheter lock concentrations eradicates mature biofilms of Candida lusitaniae and Candida guilliermondii.

Simitsopoulou M, Kyrpitzi D, Velegraki A, Walsh TJ, Roilides E.

Antimicrob Agents Chemother. 2014 Aug;58(8):4953-6. doi: 10.1128/AAC.03117-14. Epub 2014 Jun 2.

36.

Cluster of Fusarium verticillioides bloodstream infections among immunocompetent patients in an internal medicine department after reconstruction works in Larissa, Central Greece.

Georgiadou SP, Velegraki A, Arabatzis M, Neonakis I, Chatzipanagiotou S, Dalekos GN, Petinaki E.

J Hosp Infect. 2014 Apr;86(4):267-71. doi: 10.1016/j.jhin.2014.01.011. Epub 2014 Feb 27.

PMID:
24650721
37.

Sequence-based identification, genotyping and EUCAST antifungal susceptibilities of Trichosporon clinical isolates from Greece.

Arabatzis M, Abel P, Kanellopoulou M, Adamou D, Alexandrou-Athanasoulis H, Stathi A, Platsouka E, Milioni A, Pangalis A, Velegraki A.

Clin Microbiol Infect. 2014 Aug;20(8):777-83. doi: 10.1111/1469-0691.12501. Epub 2014 Jan 22.

38.

Efficient identification of Malassezia yeasts by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS).

Kolecka A, Khayhan K, Arabatzis M, Velegraki A, Kostrzewa M, Andersson A, Scheynius A, Cafarchia C, Iatta R, Montagna MT, Youngchim S, Cabañes FJ, Hoopman P, Kraak B, Groenewald M, Boekhout T.

Br J Dermatol. 2014 Feb;170(2):332-41. doi: 10.1111/bjd.12680.

PMID:
24125026
39.

Treatment of invasive candidiasis in the elderly: a review.

Flevari A, Theodorakopoulou M, Velegraki A, Armaganidis A, Dimopoulos G.

Clin Interv Aging. 2013;8:1199-208. doi: 10.2147/CIA.S39120. Epub 2013 Sep 9.

40.

Skin diseases associated with Malassezia yeasts: facts and controversies.

Gaitanis G, Velegraki A, Mayser P, Bassukas ID.

Clin Dermatol. 2013 Jul-Aug;31(4):455-463. doi: 10.1016/j.clindermatol.2013.01.012. Review.

PMID:
23806162
41.

Single-dose pharmacodynamics of amphotericin B against Aspergillus species in an in vitro pharmacokinetic/pharmacodynamic model.

Al-Saigh R, Siopi M, Siafakas N, Velegraki A, Zerva L, Meletiadis J.

Antimicrob Agents Chemother. 2013 Aug;57(8):3713-8. doi: 10.1128/AAC.02484-12. Epub 2013 May 28.

42.

Successful control of an echovirus 6 meningitis outbreak in a neonatal intensive care unit in central Greece.

Siafakas N, Goudesidou M, Gaitana K, Gounaris A, Velegraki A, Pantelidi K, Zerva L, Petinaki E.

Am J Infect Control. 2013 Nov;41(11):1125-8. doi: 10.1016/j.ajic.2013.02.014. Epub 2013 May 21.

PMID:
23706831
43.

Identification of medically relevant species of arthroconidial yeasts by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Kolecka A, Khayhan K, Groenewald M, Theelen B, Arabatzis M, Velegraki A, Kostrzewa M, Mares M, Taj-Aldeen SJ, Boekhout T.

J Clin Microbiol. 2013 Aug;51(8):2491-500. doi: 10.1128/JCM.00470-13. Epub 2013 May 15.

44.

Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates.

Simitsopoulou M, Peshkova P, Tasina E, Katragkou A, Kyrpitzi D, Velegraki A, Walsh TJ, Roilides E.

Antimicrob Agents Chemother. 2013 Jun;57(6):2562-70. doi: 10.1128/AAC.02541-12. Epub 2013 Mar 25.

45.

Malassezia yeasts produce a collection of exceptionally potent activators of the Ah (dioxin) receptor detected in diseased human skin.

Magiatis P, Pappas P, Gaitanis G, Mexia N, Melliou E, Galanou M, Vlachos C, Stathopoulou K, Skaltsounis AL, Marselos M, Velegraki A, Denison MS, Bassukas ID.

J Invest Dermatol. 2013 Aug;133(8):2023-30. doi: 10.1038/jid.2013.92. Epub 2013 Feb 28.

46.

An unusual cluster of Acremonium kiliense fungaemias in a haematopoietic cell transplantation unit.

Ioakimidou A, Vyzantiadis TA, Sakellari I, Arabatzis M, Smias C, Douka V, Velegraki A, Anagnostopoulos A, Malissiovas N.

Diagn Microbiol Infect Dis. 2013 Mar;75(3):313-6. doi: 10.1016/j.diagmicrobio.2012.11.015. Epub 2013 Jan 3.

PMID:
23290506
47.

Sexual reproduction in the opportunistic human pathogen Aspergillus terreus.

Arabatzis M, Velegraki A.

Mycologia. 2013 Jan-Feb;105(1):71-9. doi: 10.3852/11-426. Epub 2012 Oct 16.

PMID:
23074177
48.

Autochthonous and dormant Cryptococcus gattii infections in Europe.

Hagen F, Colom MF, Swinne D, Tintelnot K, Iatta R, Montagna MT, Torres-Rodriguez JM, Cogliati M, Velegraki A, Burggraaf A, Kamermans A, Sweere JM, Meis JF, Klaassen CH, Boekhout T.

Emerg Infect Dis. 2012 Oct;18(10):1618-24. doi: 10.3201/eid1810.120068.

49.

Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates.

Steinbach WJ, Roilides E, Berman D, Hoffman JA, Groll AH, Bin-Hussain I, Palazzi DL, Castagnola E, Halasa N, Velegraki A, Dvorak CC, Charkabarti A, Sung L, Danziger-Isakov L, Lachenauer C, Arrieta A, Knapp K, Abzug MJ, Ziebold C, Lehrnbecher T, Klingspor L, Warris A, Leckerman K, Martling T, Walsh TJ, Benjamin DK Jr, Zaoutis TE; International Pediatric Fungal Network.

Pediatr Infect Dis J. 2012 Dec;31(12):1252-7. doi: 10.1097/INF.0b013e3182737427.

PMID:
22982980
50.

In vitro pharmacokinetic/pharmacodynamic modeling of voriconazole activity against Aspergillus species in a new in vitro dynamic model.

Al-Saigh R, Elefanti A, Velegraki A, Zerva L, Meletiadis J.

Antimicrob Agents Chemother. 2012 Oct;56(10):5321-7. doi: 10.1128/AAC.00549-12. Epub 2012 Aug 6.

Supplemental Content

Loading ...
Support Center